Raloxifene neutralizes bone brittleness induced by anti-remodeling treatment and increases fatigue life through non-cell mediated mechanisms. (2024). Actualizaciones En Osteología, 12(3), 169-179. https://ojs.osteologia.org.ar/aaomm/index.php/osteologia/article/view/310